USPTO serial 50167871
EARLIPOINT ASSESSMENT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with EARLIPOINT ASSESSMENT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
CHRISTOPHER D. OLSZYK, JR.
CHRISTOPHER D. OLSZYK, JR. FOX ROTHSCHILD LLP212 Carnegie Center, Suite 400Princeton, NJ 08540United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable or recorded software for use in enabling objective diagnosis, tracking of symptoms, and measuring outcomes for individuals having autism spectrum and other neurodevelopmental or cognitive conditions and disorders; Downloadable or recorded software for biometric data analytics; Downloadable or recorded software for collection and analysis of eye-tracking, blink data and other human biometric data; downloadable or recorded software for displaying stimuli to users and collecting eye-movement, blink, and other data in response thereto; Scientific apparatus, namely, apparatus for displaying stimuli to users and collecting eye-movement, blink, and other data in response thereto, not for medical use.; downloadable or recorded software for detecting, assessment, screening, monitoring, or diagnosis of autism spectrum and other neurodevelopmental or cognitive conditions and disorders | ACTIVE | Jul 6, 2026 |
| 010 | Medical device for use in enabling objective diagnosis, tracking of symptoms, and measuring outcomes for individuals having autism spectrum and other neurodevelopmental or cognitive conditions and disorders; Medical device, namely, a device for detecting and assessing autism spectrum and other neurodevelopmental conditions and disorders; medical device for assessment, screening, monitoring, or diagnosis of autism spectrum and other neurodevelopmental or cognitive conditions and disorders; medical device for collection and analysis of eye-tracking and blink data and other human biometric data; medical eye-tracking and blink-detection device for detecting autism spectrum and other neurodevelopmental or cognitive conditions and disorders | ACTIVE | May 4, 2026 |
| 042 | Platform as a service (PAAS) featuring computer software platforms for use in enabling objective diagnosis, tracking of symptoms, and measuring outcomes for individuals having autism spectrum and other neurodevelopmental or cognitive conditions and disorders; Software as a service (SAAS) service featuring software for human biometric data management, data synchronization, data analytics, data automation, and data integration; Computer services, namely, providing data as a service (DaaS) featuring software for collecting, analyzing, integrating, transforming and providing access to human biometric data and information; Providing online non-downloadable software for detecting and assessing autism spectrum and other neurodevelopmental conditions and disorders; Software as a service (SaaS) services featuring software for detecting and assessing autism spectrum and other neurodevelopmental conditions and disorders; Platform as a service (PAAS) featuring computer software platforms for detecting and assessing autism spectrum and other neurodevelopmental conditions and disorders; Providing online non-downloadable software for assessment, screening, monitoring, or diagnosis of autism spectrum and other neurodevelopmental or cognitive conditions and disorders; Providing online non-downloadable software for collection and analysis of eye-tracking, blink data, and other human biometric data; providing online non-downloadable software for displaying stimuli to users and collecting eye-movement, blink, and other human biometric data in response thereto; Artificial intelligence as a service (AIAAS) featuring software using artificial intelligence for analyzing data and interacting with humans. | ACTIVE | May 4, 2026 |
| 044 | Medical testing services for the purpose of enabling objective diagnosis, tracking of symptoms, and measuring outcomes for individuals having autism spectrum and other neurodevelopmental or cognitive conditions and disorders; Medical testing for diagnostic assessment, detecting and treatment in the field of autism spectrum and other neurodevelopmental conditions and disorders; Providing information in the field of autism spectrum and other neurodevelopmental conditions and disorders; Assessing, screening, monitoring, or diagnosing of autism spectrum and other neurodevelopmental or cognitive conditions and disorders; Collecting and analyzing eye-tracking and blink data for detection of autism spectrum and other neurodevelopmental conditions and disorders. | ACTIVE | Oct 7, 2025 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 18, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 18, 2026 | NWAP | NEW APPLICATION ENTERED | — |